Ambar Protein Industries reports FY26 net profit of ₹702.66 lakh
Ambar Protein Industries Limited reported a net profit of ₹702.66 lakh for the financial year ended March 31, 2026, on revenue from operations of ₹50,065.59 lakh. The Board approved the audited standalone financial results, re-appointed Rajendra Natverlal Shah & Co. as internal auditor, and approved related party transactions with Ankur Oil Industries.

*this image is generated using AI for illustrative purposes only.
Ambar Protein Industries Limited reported a net profit of ₹702.66 lakh for the financial year ended March 31, 2026, while revenue from operations increased to ₹50,065.59 lakh. The company's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, during a meeting held on May 30, 2026. The statutory auditor, M/s. Fenil P Shah and Associates, issued an audit report with an unmodified opinion on the standalone financial results.
For the quarter ended March 31, 2026, the company recorded a net profit of ₹246.41 lakh on revenue from operations of ₹14,679.97 lakh. Total income for the quarter stood at ₹14,701.83 lakh, while total expenses were ₹14,358.80 lakh. The basic and diluted earnings per share (EPS) for the quarter were reported at ₹4.29 each.
The full-year financial performance showed a total income of ₹50,143.72 lakh against total expenses of ₹49,205.13 lakh. The profit before tax for the year was ₹938.59 lakh, with a total tax expense of ₹235.93 lakh. Basic and diluted EPS for the year were ₹12.22. The company's only business segment is the manufacturing and selling of edible oil.
Financial Results for FY26
| Particulars | Year Ended 31.03.2026 (₹ in Lacs) | Year Ended 31.03.2025 (₹ in Lacs) |
|---|---|---|
| Revenue from operations | 50,065.59 | 42,162.30 |
| Total Income | 50,143.72 | 42,246.46 |
| Total Expenses | 49,205.13 | 40,943.36 |
| Profit before tax | 938.59 | 1,303.11 |
| Net Profit | 702.66 | 965.02 |
| Basic EPS (₹) | 12.22 | 16.78 |
Board Decisions
The Board approved the re-appointment of Rajendra Natverlal Shah & Co. as the internal auditor for FY 2026-27. Additionally, the Board approved related party transactions with Ankur Oil Industries regarding the sale of goods and job work, subject to shareholder approval. The company confirmed that the financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed by the Audit Committee.
Historical Stock Returns for Ambar Protein Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.44% | -0.05% | +8.31% | -34.56% | -11.57% | +2,417.01% |
What strategies will Ambar Protein Industries implement to reverse the decline in net profit and profit before tax compared to the previous fiscal year?
How will the company manage the rising total expenses, which grew faster than revenue, to improve profit margins in FY27?
What impact will the approved related party transactions with Ankur Oil Industries have on the company's operational efficiency and revenue streams?


































